Zai Lab

Zai Lab Operating Cash Flow

The Operating Cash Flow of Zai Lab (ZLAB) as of Oct 24, 2026 is -150.79 M USD. In the previous year, Operating Cash Flow was -214.87 M USD — a change of -29.82% (higher).

Operating Cash Flow

-150.79 MUSD

YoY

-29.82%

Last updated:

Operating Cash Flow of Zai Lab is 2025 -150.79 M USD. Operating Cash Flow of Zai Lab was 2024 -214.87 M USD. It decreases by -29.82% higher compared to the previous year.

The Zai Lab Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
-97.54 M USD
Jan 1, 2019
-191.01 M USD
Jan 1, 2020
-216.06 M USD
Jan 1, 2021
-549.23 M USD
Jan 1, 2022
-367.64 M USD
Jan 1, 2023
-198.18 M USD
Jan 1, 2024
-214.87 M USD
Jan 1, 2025
-150.79 M USD
The Zai Lab Operating Cash Flow history
YEAROperating Cash FlowYoY
-150.79 MUSD-29.82%
-214.87 MUSD+8.42%
-198.18 MUSD-46.09%
-367.64 MUSD-33.06%
-549.23 MUSD+154.21%
-216.06 MUSD+13.11%
-191.01 MUSD+95.83%
-97.54 MUSD+201.35%
-32.37 MUSD+0.65%
-32.16 MUSD+180.49%
-11.46 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

Operating Cash Flow of Zai Lab is -150.79 M USD in 2025.

Operating Cash Flow of Zai Lab changed from -214.87 M USD to -150.79 M USD, representing a -29.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Zai Lab since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Zai Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Zai Lab

All Key Metrics — Zai Lab